Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cerebellar Neuromodulation to Enhance Fear Extinction and Predict Response to Exposure Therapy

NCT03275337 is registered in ClinicalTrials.gov with Laureate Institute for Brain Research, Inc. as lead sponsor.

NCT NCT03275337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03275337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cerebellar Neuromodulation to Enhance Fear Extinction and Predict Response to Exposure Therapy
Lead sponsor
Laureate Institute for Brain Research, Inc.
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2017
Completion date
December 31, 2019
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders, social phobia